fibroproliferative

Fibroproliferative refers to a process characterized by the excessive proliferation of fibroblasts and the deposition of extracellular matrix, primarily collagen. This often leads to the formation of fibrotic tissue, which can alter the normal structure and function of affected organs. Fibroproliferative disorders can arise from a variety of stimuli, including injury, inflammation, infection, and certain genetic conditions.

The cellular mechanisms involved typically include the activation of quiescent fibroblasts into myofibroblasts, which possess contractile properties and secrete large amounts of extracellular matrix components. This activation can be triggered by growth factors, cytokines, and mechanical stress. Over time, the accumulation of this fibrotic tissue can lead to organ damage, such as stiffening, loss of elasticity, and impaired function.

Examples of fibroproliferative conditions include pulmonary fibrosis, liver cirrhosis, and keloid formation. Treatment strategies often aim to inhibit fibroblast activation and extracellular matrix deposition, or to manage the underlying cause of the fibrotic process. Research continues to explore novel therapeutic targets to better understand and treat these complex disorders.